남성 불임증 시장 규모, 점유율, 동향, 성장 분석(2026-2034년)

The global male infertility market size is expected to reach USD 1426.53 Million in 2034 from USD 811.40 Million in 2025, growing at a CAGR of 6.47 during 2026-2034.This market is expanding rapidly as awareness regarding male reproductive health continues to improve worldwide. Rising infertility prevalence, changing lifestyle patterns, delayed parenthood, and increasing exposure to environmental risk factors are encouraging more individuals to seek diagnosis and treatment. Growing acceptance of fertility testing and improved access to specialized healthcare services are further supporting industry expansion across both developed and emerging markets.

Technological advancements in diagnostic procedures, assisted reproductive technologies, and minimally invasive treatment options are significantly driving market development. Healthcare providers are introducing advanced semen analysis systems, genetic testing solutions, and hormone therapies that improve diagnostic accuracy and treatment outcomes. Increasing healthcare investments and expanding fertility clinic networks are making reproductive healthcare more accessible to a broader patient population.

Future prospects remain highly positive as personalized medicine, artificial intelligence-assisted diagnostics, and advanced fertility treatments continue evolving. Ongoing research into male reproductive disorders and innovative therapeutic solutions is expected to improve treatment success rates. Greater public awareness, supportive healthcare policies, and expanding investments in reproductive medicine will continue creating substantial opportunities throughout the forecast period.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Techniques

• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Penetration Assay
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Others

By Condition Type

• Primary Male Infertility
• Secondary Male Infertility

By End-user

• Hospitals and Clinics
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• Andrology Solutions, Bonraybio Co. Ltd., Caerus Biotech, CinnaGen Co., CooperSurgical Inc., FertiPro N.V., Halotech DNA S.L., Hamilton Thorne Ltd., Medical Electronic Systems LLC (MES), Merck KGaA, MotilityCount ApS, Nidacon International AB, PROiSER R+D S.L., SCSA Diagnostics Inc., Sperm Processor Pvt. Ltd., Vitrolife AB, Zydus Healthcare Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MALE INFERTILITY MARKET: BY TECHNIQUES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Techniques
• 4.2. DNA Fragmentation Technique Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oxidative Stress Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microscopic Examination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sperm Penetration Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Sperm Agglutination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Computer Assisted Semen Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MALE INFERTILITY MARKET: BY CONDITION TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Condition Type
• 5.2. Primary Male Infertility Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Secondary Male Infertility Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MALE INFERTILITY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MALE INFERTILITY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Techniques
  • 7.2.2 By Condition Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Techniques
  • 7.3.2 By Condition Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Techniques
  • 7.4.2 By Condition Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Techniques
  • 7.5.2 By Condition Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Techniques
  • 7.6.2 By Condition Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MALE INFERTILITY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Andrology Solutions
  • 9.2.2 Bonraybio Co. Ltd
  • 9.2.3 Caerus Biotech
  • 9.2.4 CinnaGen Co
  • 9.2.5 CooperSurgical Inc
  • 9.2.6 FertiPro N.V
  • 9.2.7 Halotech DNA S.L
  • 9.2.8 Hamilton Thorne Ltd
  • 9.2.9 Medical Electronic Systems LLC (MES)
  • 9.2.10 Merck KGaA
  • 9.2.11 MotilityCount ApS
  • 9.2.12 Nidacon International AB
  • 9.2.13 PROiSER R+D S.L
  • 9.2.14 SCSA Diagnostics Inc
  • 9.2.15 Sperm Processor Pvt. Ltd
  • 9.2.16 Vitrolife AB
  • 9.2.17 Zydus Healthcare Limited